Inspire Medical Systems (INSP) Cash from Operations Growth (3y) (2020 - 2026)
Inspire Medical Systems (INSP) Cash from Operations Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 9.30% |
| 10 | Inspire Medical Systems | 1.80 Bn | 1.48 Bn | 171.46 Mn | 65.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.85% |
| Mar 31, 2026 | 126.11% |
| Dec 31, 2025 | 39.64% |
| Sep 30, 2025 | 83.99% |
| Jun 30, 2025 | 34.82% |
| Mar 31, 2025 | 19.29% |
| Dec 31, 2024 | 355.09% |
| Sep 30, 2024 | 439.11% |
| Jun 30, 2024 | 80.24% |
| Mar 31, 2024 | 41.81% |
| Dec 31, 2023 | 83.72% |
| Sep 30, 2023 | 34.04% |
| Jun 30, 2023 | 30.09% |
| Mar 31, 2023 | 55.03% |
| Dec 31, 2022 | 72.93% |
| Sep 30, 2022 | 79.02% |
| Jun 30, 2022 | 22.69% |
| Mar 31, 2022 | -5.22% |
| Dec 31, 2021 | 31.68% |
| Sep 30, 2021 | 54.35% |